论文部分内容阅读
本文采用酶联免疫法对７１例肺癌患者治疗前后血清ＩｇＥ水平进行检测，结果显示：治疗前明显高于正常对照组（Ｐ＜０．００１）；其中疗效差的１５例进展肺场血清ＩｇＥ水平与治疗前无差别（Ｐ＞０．１０）；１２例治疗后临床完全缓解者血清ＩｇＥ水平，治疗前稍高，治疗后即明显下降（ｐ＜０．００１），本文认为肺癌患者的血清ＩｇＥ水平检测对肺癌疗效及预后的判定有重要意义。
In this study, serum IgE levels in 71 patients with lung cancer before and after treatment were detected by enzyme-linked immunosorbent assay. The results showed that: before treatment, significantly higher than the normal control group (P <0.001); 15 of them with poor efficacy of the progress of lung IgE levels There was no difference with pretreatment (P>0.10); serum IgE levels in 12 patients with clinical complete remission after treatment were slightly higher before treatment and significantly decreased after treatment (p<0.001). This article considers serum IgE in patients with lung cancer. The level of detection is important for the determination of the efficacy and prognosis of lung cancer.